MX368393B - Preparacion de vacunas vivas. - Google Patents

Preparacion de vacunas vivas.

Info

Publication number
MX368393B
MX368393B MX2015007195A MX2015007195A MX368393B MX 368393 B MX368393 B MX 368393B MX 2015007195 A MX2015007195 A MX 2015007195A MX 2015007195 A MX2015007195 A MX 2015007195A MX 368393 B MX368393 B MX 368393B
Authority
MX
Mexico
Prior art keywords
preparation
live vaccines
vaccine containing
live
bacteria
Prior art date
Application number
MX2015007195A
Other languages
English (en)
Other versions
MX2015007195A (es
Inventor
Linde Klaus
Grosse-Herrenthey Anke
Original Assignee
Lohmann Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health Gmbh filed Critical Lohmann Animal Health Gmbh
Priority claimed from PCT/EP2013/068373 external-priority patent/WO2014037445A1/en
Publication of MX2015007195A publication Critical patent/MX2015007195A/es
Publication of MX368393B publication Critical patent/MX368393B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un método para la generación de una vacuna viva que contiene bacterias estables que llevan al menos tres mutaciones atenuadoras y una vacuna que contiene bacterias obtenidas mediante dicho método.
MX2015007195A 2012-12-07 2013-09-05 Preparacion de vacunas vivas. MX368393B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12008206 2012-12-07
PCT/EP2013/068373 WO2014037445A1 (en) 2012-09-05 2013-09-05 Preparation of live vaccines

Publications (2)

Publication Number Publication Date
MX2015007195A MX2015007195A (es) 2016-03-07
MX368393B true MX368393B (es) 2019-10-01

Family

ID=47355770

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007195A MX368393B (es) 2012-12-07 2013-09-05 Preparacion de vacunas vivas.

Country Status (15)

Country Link
US (3) US10828362B2 (es)
EP (3) EP3714899A1 (es)
JP (1) JP6336461B2 (es)
KR (1) KR101835946B1 (es)
CN (2) CN112760252A (es)
AU (2) AU2013311675A1 (es)
BR (1) BR112015011944A8 (es)
CA (1) CA2901322C (es)
EA (1) EA030355B1 (es)
ES (2) ES2686325T3 (es)
HK (1) HK1213949A1 (es)
MX (1) MX368393B (es)
NZ (1) NZ709154A (es)
PL (2) PL3415643T3 (es)
PT (1) PT2929058T (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3714899A1 (en) * 2012-09-05 2020-09-30 Elanco Tiergesundheit AG Preparation of live vaccines
CN114107162A (zh) * 2021-12-08 2022-03-01 塔里木大学 诱导细菌形成小菌落变异体的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE294420C (es)
DE3751641D1 (de) * 1986-10-10 1996-02-01 Tad Pharm Werk Salmonella-Lebendimpfstoffe mit Wirtsspezies-angepassten Attenuierungshöhen und antiepidemischer Potenz
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
DD294420A5 (de) * 1990-05-18 1991-10-02 Karl-Marx-Universitaet Leipzig,De Verfahren zur herstellung von lebendimpfstoffen gegen listeriose
DE69132058D1 (de) * 1990-12-18 2000-04-20 Gen Hospital Corp Verbesserte impfstoffe
US6136325A (en) 1993-04-09 2000-10-24 Lohmann Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
DE10299020I2 (de) * 1993-09-04 2007-12-27 Lohmann Animal Health Gmbh Salmonella-Lebendimpfstoff
DE4333742A1 (de) * 1993-10-04 1995-04-06 Klaus Prof Dr Linde Lebendimpfstoff mit erhöhter Stabilität
US6479056B1 (en) 1994-09-02 2002-11-12 Lohman Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
GB0024203D0 (en) * 2000-10-03 2000-11-15 Peptide Therapeutics Ltd Stabilisation of plasmid inheritance in bacteria
US20050180985A9 (en) * 2001-10-04 2005-08-18 Vladoianu Ion R. Live attenuated salmonella strains for producing monovalent or multivalent vaccines
GB0308691D0 (en) * 2003-04-07 2003-05-21 Xenova Res Ltd Vaccine preparations
CA2556095A1 (en) * 2004-02-12 2005-08-25 The University Of Queensland Live attenuated salmonella for use as vaccine
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
DE102007012824A1 (de) * 2007-03-17 2008-09-18 Universität Leipzig Impfstämme mit abgestuften Koloniegrößen/Attenuierungen und Verfahren zu deren Isolierung
DE102008062941A1 (de) * 2008-12-23 2010-07-01 Universität Leipzig Impfstämme gegen bakterielle und fungale Infektionen
EP3714899A1 (en) * 2012-09-05 2020-09-30 Elanco Tiergesundheit AG Preparation of live vaccines

Also Published As

Publication number Publication date
AU2017219152A1 (en) 2017-09-21
PT2929058T (pt) 2018-07-27
EA201590856A1 (ru) 2015-09-30
CA2901322A1 (en) 2014-03-13
ES2686325T3 (es) 2018-10-17
MX2015007195A (es) 2016-03-07
US11904008B2 (en) 2024-02-20
EA030355B1 (ru) 2018-07-31
HK1213949A1 (zh) 2016-07-15
NZ709154A (en) 2019-10-25
EP3415643B1 (en) 2020-02-19
PL3415643T3 (pl) 2020-06-01
US20150297705A1 (en) 2015-10-22
CN104995292A (zh) 2015-10-21
ES2776429T3 (es) 2020-07-30
US20240181031A1 (en) 2024-06-06
PL2929058T3 (pl) 2018-11-30
EP2929058B1 (en) 2018-07-11
CN112760252A (zh) 2021-05-07
JP6336461B2 (ja) 2018-06-06
KR101835946B1 (ko) 2018-03-07
JP2015536142A (ja) 2015-12-21
EP2929058A1 (en) 2015-10-14
US20220088168A1 (en) 2022-03-24
EP3714899A1 (en) 2020-09-30
KR20150082480A (ko) 2015-07-15
BR112015011944A2 (pt) 2017-07-11
US10828362B2 (en) 2020-11-10
AU2013311675A1 (en) 2015-05-21
CA2901322C (en) 2019-07-02
BR112015011944A8 (pt) 2019-10-08
EP3415643A1 (en) 2018-12-19
AU2017219152B2 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
PH12017500962A1 (en) Novel european prrsv strain
EP3071229A4 (en) Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
ZA201400368B (en) Methods and compositions for producing male sterile plants
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
EP2998322A4 (en) EPITOPE BASED VACCINE FOR LOW IMMUNOGENICITY PROTEIN AND METHOD FOR PREPARING AND USING SAME
IN2014DN11201A (es)
MX354988B (es) Formulaciones de anticuerpo y metodos.
MX349119B (es) Vacuna de virus de dengue inactivado.
PH12015501171A1 (en) Device for conveying fuels into a gasification reactor
IN2014DN06169A (es)
PL3073959T3 (pl) Zespól szczepiący do podawania szczepionki do młodej kury
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
MX2016014099A (es) Productos de esmalte y metodos de uso.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
HUE051711T2 (hu) Influenzavakcina antigénjeinek koncentrálása liofilizálás nélkül
IL234415B (en) Garlic plants with male sterility, hybrid offspring and methods of their creation and use
UY34286A (es) Diagnóstico de vacuna mejorado
ZA201600098B (en) Plant produced human papillomavirus pseudovirion
MX368393B (es) Preparacion de vacunas vivas.
EP2929894A4 (en) VACCINE ADJUVANS, PREPARATION AND VACCINES THEREOF
AP2013006777A0 (en) Animal model for the elevation of the efficacy of an HIV vaccine
PT2884996T (pt) Uma composição imunogénica de bactérias de leptospira mortas
GB201300891D0 (en) Vaccine production via irradiation of pathogenic cultures
UA59897U (ru) Способ изготовления вакцины против бешенства животных "рабизин"

Legal Events

Date Code Title Description
FG Grant or registration